Leptomeningeal inflammation, characterized by increased numbers of circulating and long‐lived B cells, plasma cells and large numbers of CD4+ and CD8+ T cells, is seen in a substantial proportion of MS cases, where it may play an important role in initiating and/or modulating demyelinating pathology (10). This evidence concerns the gene CD4 and myeloid sarcoma.